Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first‐line induction therapy for newly diagnosed multiple myeloma in a single institution of China
Xiaoning Wang; Pengcheng He; Caili Guo; Chunhong Sun; Mei Zhang
Author Information: Department of Hematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.